+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bird Flu Treatment Market by Product Type, Administration Route, End User, Application - Global Forecast to 2030- Product Image
Bird Flu Treatment Market by Product Type, Administration Route, End User, Application - Global Forecast to 2030- Product Image
Sale

Bird Flu Treatment Market by Product Type, Administration Route, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010916
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bird Flu Treatment Market grew from USD 23.85 billion in 2024 to USD 25.86 billion in 2025. It is expected to continue growing at a CAGR of 8.21%, reaching USD 38.30 billion by 2030.

Harnessing Strategic Insight to Confront Bird Flu Threats

Avian influenza continues to present evolving challenges to global health systems, demanding a forward-looking strategic perspective. This report opens with a comprehensive overview of the current bird flu treatment landscape, highlighting the interplay between emerging viral strains and the accelerating innovation in therapeutic modalities. As zoonotic transmission patterns shift, stakeholders must adapt to a dynamic environment where antiviral development, diagnostic advancements, supportive care protocols, and vaccination strategies converge.

In this context, decision-makers require clarity on the drivers reshaping investment priorities and research trajectories. This introductory section outlines the critical themes explored throughout the analysis: the transformative role of novel antivirals, the integration of digital and point-of-care diagnostics, the scaling of supportive care infrastructure, and the diversification of vaccine platforms. By establishing this foundation, executives, researchers, and policymakers will gain a cohesive framework for understanding the multifaceted challenges and opportunities that define bird flu treatment today.

Navigating Pivotal Transformations in the Bird Flu Ecosystem

The bird flu ecosystem is undergoing a fundamental shift driven by breakthroughs in molecular science, data analytics, and patient-centered care models. Antiviral pipelines are expanding beyond traditional neuraminidase inhibitors to embrace combination therapies that target multiple viral processes simultaneously. At the same time, molecular and rapid diagnostics are converging with telehealth platforms, enabling real-time surveillance and timely intervention in decentralized settings.

Moreover, regulatory pathways are adapting to accelerated review processes for mRNA-based vaccines and recombinant immunotherapies, reflecting lessons learned from recent pandemic responses. Supply chain resilience has become paramount, prompting collaborations across pharmaceutical, logistics, and digital health partners. These shifts are further compounded by evolving patient expectations for minimally invasive administration routes and integrated care bundles. Together, these transformations are redefining how stakeholders approach prevention, detection, and treatment of avian influenza on a global scale.

Assessing the Ripple Effects of US Tariffs on Bird Flu Treatments

United States tariff policies introduced in 2025 have introduced new variables into the procurement and distribution of bird flu treatment modalities. Import duties on active pharmaceutical ingredients and specialized diagnostic components have increased production costs, compelling manufacturers to reassess global sourcing strategies. As a result, some firms have relocated manufacturing to tariff-free zones or established in-country partnerships to mitigate additional overhead.

These measures have also influenced collaborative research initiatives, with stakeholders exploring technology transfers and shared-cost pilot programs to preserve affordability and maintain supply reliability. In parallel, distributors and end users are negotiating long-term contracts that incorporate tariff-contingent clauses, safeguarding margin stability despite external trade pressures. By understanding these cumulative effects, industry participants can better navigate evolving tariff landscapes and align supply chain decisions with broader business objectives.

Unveiling Four-Dimensional Market Segmentation Dynamics

A four-dimensional segmentation framework reveals nuanced insights into the bird flu treatment market. The product type dimension spans antiviral drugs, diagnostic kits, supportive care solutions, and vaccines, each with distinct subcategories such as adamantanes and neuraminidase inhibitors, molecular diagnostics and rapid test kits, oxygen therapy and telehealth monitoring, as well as inactivated, mRNA, and recombinant vaccines. This layered perspective underscores how innovation trajectories differ across modalities.

Administration route considerations further differentiate market dynamics, with inhalation approaches like dry powder inhalers and nebulizers, injectable formats including nanoparticle delivery systems, intravenous platforms leveraging smart infusion pumps, and diverse oral forms driving distinct adoption curves. End user segmentation highlights the varying service models across clinics-from community health centers to specialty outpatient facilities-hospitals spanning private to specialized care centers, laboratory settings from point-of-care testing to independent labs, and pharmacy channels ranging from retail to mail-order operations. Finally, the application axis distinguishes animal health deployments in livestock, poultry, and wild birds from human health strategies targeting adult, geriatric, and pediatric patient populations. Together these four lenses enable stakeholders to tailor strategies with precision across product, channel, and end-use landscapes.

Regional Nuances Shaping Global Bird Flu Responses

Regional variances play a critical role in shaping both demand and innovation pathways for bird flu treatments. In the Americas, robust public-private partnerships and established distribution networks accelerate the uptake of advanced antivirals and digital diagnostics, while regulatory harmonization across North and South American health authorities fosters cross-border collaboration. Moving to Europe, Middle East & Africa, diverse healthcare infrastructures and funding mechanisms create a mosaic of access models, prompting manufacturers to deploy tiered pricing strategies and region-specific clinical support programs.

In Asia-Pacific, rapid industrialization of biotech hubs, coupled with concentrated poultry farming, has elevated both research investment and urgency for scalable vaccine production. Here, governmental incentives and technology transfer agreements are driving local production capacity, while telehealth innovations bridge urban-rural divides. By comparing these region-specific drivers and constraints, stakeholders can pinpoint opportunities for strategic partnerships, tailored market entry tactics, and optimized resource allocation across global territories.

Corporate Strategies Driving Treatment Innovation

Leading life sciences and biotech firms are charting distinct paths to capture emerging opportunities in bird flu treatment. Key players leverage proprietary pipelines focused on broad-spectrum polymerase inhibitors and next-generation vaccine platforms, while strategic alliances with diagnostic technology companies enhance integrated care offerings. Some organizations differentiate through vertical integration, combining in-house manufacturing of mRNA vaccines with direct distribution partnerships to streamline time to market.

Meanwhile, contract research organizations and specialized distributors are capitalizing on outsourced testing and supply chain management needs, deploying flexible models that serve both established manufacturers and agile biotech startups. Investment in digital health capabilities-such as AI-enabled diagnostic interpretation and remote patient monitoring-further sets certain companies apart, enabling preventive interventions and data-driven decision support. By examining each player’s unique positioning, innovation focus, and collaborative ventures, stakeholders can assess competitive intensity and identify potential alliance opportunities for shared growth.

Actionable Paths for Industry Leadership in Avian Influenza

Industry leaders should prioritize integrated R&D roadmaps that align antiviral development with diagnostic advancements and supportive care enhancements. By fostering cross-functional collaboration between vaccine scientists and delivery system engineers, organizations can accelerate combination therapy regimens that improve patient outcomes and reduce resistance risks. It is also essential to diversify supply chains through multi-regional manufacturing hubs and strategic alliances, thereby insulating operations from tariff volatility and logistics disruptions.

Furthermore, executives must leverage data analytics to refine end user engagement, tailoring diagnostic platforms for clinics, hospitals, laboratories, and pharmacies based on specific workflow requirements and regulatory frameworks. In parallel, regional market entry strategies should be customized to reflect local healthcare funding models, ensuring that pricing, reimbursement, and patient access initiatives resonate with stakeholders across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Emphasizing digital health integration and outcome-based evidence generation will differentiate offerings in a competitive landscape and drive sustainable growth.

Rigorous Methodology Underpinning Market Intelligence

This analysis harnesses a blend of primary and secondary research methodologies to ensure comprehensive and objective insights. Secondary sources include peer-reviewed journals, regulatory filings, patent databases, and industry white papers. These were triangulated with proprietary company disclosures and trade association reports to construct a robust baseline of technology trends and market dynamics.

Primary research comprised in-depth interviews with key opinion leaders, pharmaceutical executives, supply chain specialists, and frontline healthcare practitioners. Quantitative data on clinical trial pipelines, regulatory approvals, and tariff schedules were synthesized alongside qualitative perspectives on emerging challenges and strategic priorities. Data validation processes included cross-checking against publicly available financial disclosures, government import/export records, and conference proceedings. This rigorous approach underpins the report’s credibility and ensures that recommendations reflect both empirical evidence and expert judgment.

Concluding Imperatives for Stakeholders in Bird Flu Management

In conclusion, the bird flu treatment landscape stands at an inflection point defined by scientific innovation, shifting trade policies, and region-specific healthcare dynamics. Integrating novel antiviral mechanisms with advanced diagnostics and adaptive supportive care models offers the most promising path to enhanced pandemic preparedness and patient outcomes. Stakeholders who embrace a segmented, data-driven strategy-tailored to product types, administration routes, end-user needs, and application contexts-will be best positioned to navigate evolving regulatory and tariff environments.

By synthesizing insights across regions and corporate strategies, this report has outlined clear imperatives for investment, collaboration, and operational resilience. As global health agencies and private firms pursue coordinated responses, the capacity to translate comprehensive market intelligence into agile decision-making will determine both competitive advantage and public health impact. The time to act is now.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Antiviral Drug
      • Adamantanes
      • Combination Therapy
      • Neuraminidase Inhibitors
      • Polymerase Inhibitors
    • Diagnostic Kit
      • Molecular Diagnostics
      • Point Of Care Molecular
      • Rapid Test Kits
      • Serological Diagnostics
    • Supportive Care
      • Oxygen Therapy
      • Rehydration Therapy
      • Symptom Management
      • Telehealth Monitoring
    • Vaccine
      • Inactivated Vaccine
      • Live Attenuated Vaccine
      • Mrna Vaccine
      • Recombinant Vaccine
  • Administration Route
    • Inhalation
      • Dry Powder Inhaler
      • Metered Dose Inhaler
      • Nebulizer
    • Injectable
      • Intramuscular
      • Nanoparticle Delivery
      • Subcutaneous
    • Intravenous
      • Central Line
      • Peripheral Line
      • Smart Infusion Pumps
    • Oral
      • Capsule
      • Sublingual
      • Suspension
      • Tablet
  • End User
    • Clinics
      • Community Health Centers
      • Outpatient Clinics
      • Specialty Clinics
    • Hospitals
      • Private Hospitals
      • Public Hospitals
      • Specialized Care Centers
    • Laboratories
      • Hospital Labs
      • Independent Labs
      • Point Of Care Testing
    • Pharmacies
      • Mail Order Pharmacies
      • Online Pharmacies
      • Retail Pharmacies
  • Application
    • Animal Health
      • Livestock
      • Poultry
      • Wild Birds
    • Human Health
      • Adult Patients
      • Geriatric Patients
      • Pediatric Patients
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Novartis AG
  • CSL Limited
  • Pfizer Inc.
  • Fujifilm Toyama Chemical Co., Ltd.
  • Seqirus Pty Ltd
  • Shionogi & Co., Ltd.
  • BioCryst Pharmaceuticals, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bird Flu Treatment Market, by Product Type
8.1. Introduction
8.2. Antiviral Drug
8.2.1. Adamantanes
8.2.2. Combination Therapy
8.2.3. Neuraminidase Inhibitors
8.2.4. Polymerase Inhibitors
8.3. Diagnostic Kit
8.3.1. Molecular Diagnostics
8.3.2. Point Of Care Molecular
8.3.3. Rapid Test Kits
8.3.4. Serological Diagnostics
8.4. Supportive Care
8.4.1. Oxygen Therapy
8.4.2. Rehydration Therapy
8.4.3. Symptom Management
8.4.4. Telehealth Monitoring
8.5. Vaccine
8.5.1. Inactivated Vaccine
8.5.2. Live Attenuated Vaccine
8.5.3. Mrna Vaccine
8.5.4. Recombinant Vaccine
9. Bird Flu Treatment Market, by Administration Route
9.1. Introduction
9.2. Inhalation
9.2.1. Dry Powder Inhaler
9.2.2. Metered Dose Inhaler
9.2.3. Nebulizer
9.3. Injectable
9.3.1. Intramuscular
9.3.2. Nanoparticle Delivery
9.3.3. Subcutaneous
9.4. Intravenous
9.4.1. Central Line
9.4.2. Peripheral Line
9.4.3. Smart Infusion Pumps
9.5. Oral
9.5.1. Capsule
9.5.2. Sublingual
9.5.3. Suspension
9.5.4. Tablet
10. Bird Flu Treatment Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. Community Health Centers
10.2.2. Outpatient Clinics
10.2.3. Specialty Clinics
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.3.3. Specialized Care Centers
10.4. Laboratories
10.4.1. Hospital Labs
10.4.2. Independent Labs
10.4.3. Point Of Care Testing
10.5. Pharmacies
10.5.1. Mail Order Pharmacies
10.5.2. Online Pharmacies
10.5.3. Retail Pharmacies
11. Bird Flu Treatment Market, by Application
11.1. Introduction
11.2. Animal Health
11.2.1. Livestock
11.2.2. Poultry
11.2.3. Wild Birds
11.3. Human Health
11.3.1. Adult Patients
11.3.2. Geriatric Patients
11.3.3. Pediatric Patients
12. Americas Bird Flu Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bird Flu Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bird Flu Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.2. GlaxoSmithKline plc
15.3.3. Sanofi S.A.
15.3.4. Novartis AG
15.3.5. CSL Limited
15.3.6. Pfizer Inc.
15.3.7. Fujifilm Toyama Chemical Co., Ltd.
15.3.8. Seqirus Pty Ltd
15.3.9. Shionogi & Co., Ltd.
15.3.10. BioCryst Pharmaceuticals, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIRD FLU TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. BIRD FLU TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. BIRD FLU TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIRD FLU TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIRD FLU TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIRD FLU TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADAMANTANES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POLYMERASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POINT OF CARE MOLECULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SEROLOGICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REHYDRATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SYMPTOM MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TELEHEALTH MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MRNA VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NANOPARTICLE DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CENTRAL LINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PERIPHERAL LINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SMART INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SPECIALIZED CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MAIL ORDER PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY WILD BIRDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 123. CANADA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 125. CANADA BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 126. CANADA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 127. CANADA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 128. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 129. CANADA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 130. CANADA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 131. CANADA BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 132. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 133. CANADA BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. CANADA BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 135. CANADA BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 136. CANADA BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 137. CANADA BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 138. CANADA BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 140. CANADA BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 141. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 143. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 144. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 145. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 146. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 147. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 148. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 149. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 150. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 151. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 153. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 154. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 155. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 156. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 158. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 220. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 222. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 224. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 232. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 234. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 235. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 236. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 237. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 238. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 239. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 240. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 241. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 242. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 244. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 245. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 246. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 247. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 249. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 250. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 252. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 253. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 254. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 255. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 256. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 257. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 258. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 259. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 260. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 262. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 263. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 264. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 265. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 267. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 280. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 282. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 283. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 285. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 286. ITALY BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. ITALY BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 288. ITALY BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 289. ITALY BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 290. ITALY BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 291. ITALY BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 292. ITALY BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 293. ITALY BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 294. ITALY BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 295. ITALY BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 296. ITALY BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. ITALY BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 298. ITALY BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 299. ITALY BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 300. ITALY BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 301. ITALY BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. ITALY BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 303. ITALY BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 304. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 306. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 307. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 308. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 309. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 310. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 311. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 312. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 313. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 314. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 316. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 317. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 318. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 319. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 321. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2030 (USD MILLION)
TABLE 340. SAUDI ARABIA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2030 (USD MILLION)
TABLE 342. SAUDI ARABIA BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 344. SAUDI ARABIA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 345. SAUDI ARAB

Companies Mentioned

The companies profiled in this Bird Flu Treatment market report include:
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Novartis AG
  • CSL Limited
  • Pfizer Inc.
  • Fujifilm Toyama Chemical Co., Ltd.
  • Seqirus Pty Ltd
  • Shionogi & Co., Ltd.
  • BioCryst Pharmaceuticals, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 25.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 38.3 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

H3N2 Infection - Pipeline Insight, 2025 - Product Image

H3N2 Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • 80 Pages
  • Global
From
Influenza A Virus H5N1 Subtype - Pipeline Insight, 2025 - Product Image

Influenza A Virus H5N1 Subtype - Pipeline Insight, 2025

  • Drug Pipelines
  • 40 Pages
  • Global
From
Influenza Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Influenza Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Japan Influenza Medications Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

Japan Influenza Medications Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 80 Pages
  • Japan
From
Influenza Medication - Global Strategic Business Report - Product Image

Influenza Medication - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From

About the Avian Influenza Drug Market

The Avian Influenza Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat avian influenza, a type of influenza virus that primarily affects birds, but can also infect humans. These drugs are used to reduce the severity of symptoms and prevent further spread of the virus. They are typically administered in the form of antiviral medications, such as oseltamivir and zanamivir. Vaccines are also available to help protect against avian influenza. The Avian Influenza Drug market is highly competitive, with many companies offering products to treat the virus. Some of the major players in the market include GlaxoSmithKline, Sanofi, Novartis, Merck, and Pfizer. Other companies, such as Cipla, Mylan, and Sun Pharmaceuticals, also offer products for the treatment of avian influenza. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.